Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Magyar Onkologia|November 30, 2016
[Tocilizumab treatment of HHV8-positive/HIV-negative, multricentric plasma cell type Castleman's disease]Györgyi Mûzes, Judit Csomor, Ferenc Sipos
Pathology Oncology Research : POR|March 22, 2013
Multicentric Castleman's disease: a challenging diagnosisGyörgyi Műzes, Ferenc Sipos, Judit Csomor, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 21, 2012
Successful tocilizumab treatment in a patient with human herpesvirus 8-positive and human immunodeficiency virus-negative multicentric Castleman's disease of plasma cell type nonresponsive to rituximab-CVP therapyGyörgyi Műzes, Ferenc Sipos, Judit Csomor, et al.
Orvosi Hetilap|September 16, 2010
[Case of a diabetic man cured of rhinocerebral zygomycosis]Botond Lakatos, Radka Nikolova, László Ocskay, et al.
Magyar Onkologia|March 9, 2017
[The role of driver and subclonal mutations in pathogenesis of primary myelofibrosis]Réka Mózes, Ambrus Gángó, Zsófia Boha, et al.
Orvosi Hetilap|January 25, 2005
[Mucormycosis]Judit Csomor, Radka Nikolova, János Sinkó, et al.
Histopathology|September 30, 2010
Immunohistochemical classification of ductular reactions in human liverEszter Turányi, Katalin Dezsö, Judit Csomor, et al.
Experimental Hematology & Oncology|December 6, 2012
Long lasting complete molecular remission after suspending dasatinib treatment in chronic myeloid leukemiaKlára Gadó, András Matolcsy, Judit Csomor, et al.
World Journal of Surgical Oncology|September 20, 2013
Sarcoidosis lymphoma syndrome - the value of PET-CT in the diagnosisAdrian Kis, Noemi Eszes, Lilla Tamasi, et al.
Oncotargets and Therapy|February 10, 2017
Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim-Chester diseaseZsófia Váradi, Rita Bánusz, Judit Csomor, et al.
Pageof 7